The present invention relates to pyrazine substituted pyrrolopyridines having formula (I)
useful as inhibitors of JAK kinases (JAK1, JAK2, JAK3 and/or TYK2) and/or PDK1 and for the treatment of myeloproliferative disorders or other cancers.
本发明涉及具有式(I)的
吡嗪取代的
吡咯吡啶,可用作JAK激酶(JAK1,JAK2,JAK3和/或TYK2)和/或PDK1的
抑制剂,并用于治疗骨髓增生性疾病或其他癌症。